For over a decade, and as recently as August, FDA has fully evaluated the emerging scientific evidence and repeatedly ...

Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...

“For over a decade — and as recently as August — FDA has fully evaluated the emerging scientific evidence and repeatedly ...

Kenvue, the maker of Tylenol, is urging U.S. health regulators not to add an autism warning label to it and other ...

Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...

Bessent calls $20 billion lifeline to Argentina a ‘mission-critical’ function of Treasury during shutdown ...

In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Valued at $10.7 billion by market cap, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development and ...

Intuitive Surgical shares soared after the surgical robot maker posted earnings that topped expectations. Major U.S. equities indexes slid Wednesday afternoon after a flurry of weaker-than-expected ...

Johnson & Johnson stopped selling its talc-based baby powder in the US and Canada in 2020. In 2023, it switched to a cornstarch formula. The company maintains its baby powder is safe. Its consumer ...

Tylenol's maker, Kenvue, has strongly opposed a proposed change to the product's safety label, following research suggesting ...